Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGVN | APRE | KALA | ||
| Company | Longeveron Inc | Aprea Therapeutics Inc | Kala Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.13 | 4.00 | 6.99 | ||
| High | 3.42 | 4.00 | 6.99 | ||
| Low | 2.90 | 3.99 | 6.66 | ||
| Last | 3.29 | 4.00 | 6.76 | ||
| Change | +0.04 | unch | -0.07 | ||
| % Change | +1.23% | unch | -1.02% | ||
| Volume | 2,598,000 | 1,600 | 32,300 | ||
| 20-Day Average Volume | 11,144,105 | 7,795 | 706,140 | ||
| Previous Close | 3.25 | 4.00 | 6.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.67 | 3.98 | 6.66 | ||
| 20-Day Raw Stochastic | 37.04% | 46.87% | 69.48% | ||
| 20-Day Relative Strength | 56.10% | 42.08% | 50.48% | ||
| Weighted Alpha | -96.57 | -8.22 | -53.30 | ||
| Today's Opinion | 8% Sell | 72% Sell | 40% Sell | ||
| Previous Opinion | 8% Sell | 72% Sell | 40% Sell | ||
| Last Month's Opinion | 56% Sell | 72% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.06% since 07/12/24 | -2.68% since 07/12/24 | -9.63% since 07/12/24 | ||
| Low | 2.90 on 07/19/24 | 3.92 on 07/15/24 | 6.66 on 07/19/24 | ||
| High | 4.88 on 07/17/24 | 4.16 on 07/15/24 | 7.88 on 07/15/24 | ||
| 1-Month | |||||
| %Chg | +48.20% since 06/18/24 | -1.72% since 06/18/24 | +30.00% since 06/18/24 | ||
| Low | 1.46 on 07/01/24 | 3.70 on 07/03/24 | 4.21 on 06/26/24 | ||
| High | 6.40 on 07/10/24 | 4.34 on 06/25/24 | 7.88 on 07/15/24 | ||
| 3-Month | |||||
| %Chg | +71.35% since 04/19/24 | -25.23% since 04/19/24 | +2.58% since 04/19/24 | ||
| Low | 0.77 on 06/11/24 | 3.70 on 07/03/24 | 4.21 on 06/26/24 | ||
| High | 6.40 on 07/10/24 | 5.90 on 05/16/24 | 7.88 on 07/15/24 | ||
| 6-Month | |||||
| %Chg | -65.37% since 01/19/24 | -25.79% since 01/19/24 | -8.89% since 01/19/24 | ||
| Low | 0.77 on 06/11/24 | 3.70 on 07/03/24 | 4.21 on 06/26/24 | ||
| High | 9.55 on 01/22/24 | 8.85 on 03/01/24 | 8.23 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,887 | 21,721 | 19,039 | ||
| Shares Outstanding, K | 6,349 | 5,430 | 2,816 | ||
| Annual Sales | 710,000 | 580,000 | 0 | ||
| Annual Net Income | -21,410,000 | -14,290,000 | -42,200,000 | ||
| Last Quarter Sales | 550,000 | 380,000 | 0 | ||
| Last Quarter Net Income | -4,060,000 | -2,810,000 | -11,810,000 | ||
| 60-Month Beta | 0.43 | 1.04 | -2.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.61 on 05/14/24 | -0.67 on 05/14/24 | -4.20 on 05/14/24 | ||
| Latest Earnings Date | 08/09/24 | 08/08/24 | 08/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||